GSE221577 PIK3R1 knockout 1 v 5 human dn (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE221577_PIK3R1 knockout_1_v_5_human_dn.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE221577_PIK3R1 knockout_1_v_5_human_dn.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE221577_PIK3R1 knockout_1_v_5_human_dn.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE221577_PIK3R1 knockout_1_v_5_human_dn.

Results found

Linked to

 

Label

Description

 

Gene

paternally expressed 10

Gene

TNF superfamily member 10

Gene

activated leukocyte cell adhesion molecule

Gene

tubulin beta 2A class IIa

Gene

heat shock protein family A (Hsp70) member 1A

Gene

olfactomedin 4

Gene

brain abundant membrane attached signal protein 1

Gene

protein kinase cAMP-dependent type II regulatory subunit beta

Gene

insulin receptor substrate 2

Gene

placenta associated 8

  • Gene

    paternally expressed 10


  • Gene

    TNF superfamily member 10


  • Gene

    activated leukocyte cell adhesion molecule


  • Gene

    tubulin beta 2A class IIa


  • Gene

    heat shock protein family A (Hsp70) member 1A



  • Gene

    brain abundant membrane attached signal protein 1


  • Gene

    protein kinase cAMP-dependent type II regulatory subunit beta


  • Gene

    insulin receptor substrate 2


  • Gene

    placenta associated 8

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.